ACELRX PHARMACEUTICALS INC announced its financial results for the three and twelve months ended December 31, 2022 and identified an error in the earnings per share calculations in the interim financial statements for the three and six months ended J
AI Assistant
TALPHERA INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.